🔗 Share this article

A shadow market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on communication apps, according to new investigations.

Investigational Drug Acquiring Traction Online

Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its supposed weight-reducing properties. Viewers are encouraged to contact these accounts directly for supplier links, while also obtaining discount codes.

Active Trade on Messaging Platforms

Separately, a robust trade exists on messaging services, where communities with thousands of participants share “before and after” photos, injection guides and claims of next-day UK delivery. Vendors market the substance there before redirecting buyers to WhatsApp for purchases.

Understanding The Experimental Drug

This medication is an investigational injection created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.

Medical Experts Express Concerns

However, physicians and chemists have cautions that the sale of what is still an unlicensed medication in the United Kingdom is worrisome and could lead to individuals injecting products of uncertain source.

Several professionals said the demand for the experimental drug could be connected to the increasing price of licensed slimming products such as Mounjaro.

Legal Position and Implementation

Marketing the unapproved drug on social media or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that must not be marketed or supplied for human use under the British medical regulations.

Several influencers attempt to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still violate medicines, marketing, and consumer laws, risking fines, prosecution or prison.

Service Response and Material Elimination

Based on the social media company, the platform has removed problematic content and prohibited related hashtags and query recommendations. The company said it was committed to maintaining the service safe and allocating resources in strengthening enforcement strategies.

Online Marketplace Activities

Research also discovered communities with up to nine thousand participants selling the experimental drug using the platform's built-in search feature, which operates like a online catalog. Typing “retatrutide” instantly displays channels with numerous of users, populated with photos of weight loss, glowing reviews and step-by-step guides for preparing or injecting at residence.

Within moments of joining one group, a seller posted contact information, where most transactions take place. The vendor sent an instruction manual and guaranteed shipping within two days. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a image of a alleged testing documentation. Not one asked about body mass, medical conditions or past usage.

Product Details and Costs

Inside these communities, messages show dark colored packages with postal service labels, stating to contain new batches. One message read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at home with purified liquid, or ready-to-use pens typically priced at 160 pounds for 20mg. When asked how much time a pen should last, vendors give contradictory answers ranging from a few weeks to “depends on your body”.

Service Oversight and Security Actions

A representative for the messaging service said it actively monitored harmful content on its service including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are administering materials they cannot confirm. Although the science behind retatrutide is valid, these digital products may not contain what they claim,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor connected the surge in interest to recent cost increases for authorized weight-loss medications such as Mounjaro. “With prices rising, individuals are turning to online platforms. But counterfeit injections are extremely dangerous. You can’t be certain what’s contained or whether the environment they were made in was clean,” she explained.

Her staff has previously encountered patients harmed by self-injection from unverified suppliers. “We recognize the disappointment, but purchasing from Telegram or communication platforms is taking chances with your health,” stated the doctor. “These materials could be contaminated or improperly measured.”

Manufacturer Position

A spokesperson from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this point no one can market [it] for personal consumption,” they explained, noting that any product “falsely representing itself as a Lilly experimental product not yet authorized … may expose users to possibly serious medical dangers”.